Aileen Wang
Finanzdirektor/CFO bei CLOVER BIOPHARMACEUTICALS, LTD.
Aktive Positionen von Aileen Wang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Finanzdirektor/CFO | 01.07.2022 | - |
| Corporate Officer/Principal | 01.03.2021 | - |
Karriereverlauf von Aileen Wang
Ehemalige bekannte Positionen von Aileen Wang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | - | - |
Ausbildung von Aileen Wang
| The Pennsylvania State University | Masters Business Admin |
| Shanghai Jiao Tong University | Undergraduate Degree |
Statistik
International
| China | 3 |
| Vereinigte Staaten | 3 |
Operativ
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Börse
- Insiders
- Aileen Wang
- Erfahrung